Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Tumor Biology
Published in: Tumor Biology 7/2014

01-07-2014 | Research Article

The polymorphism interleukin-8 -251A/T is associated with a significantly increased risk of cancers from a meta-analysis

Authors: Ziliang Wang, Yang Liu, Lina Yang, Sheng Yin, Rongyu Zang, Gong Yang

Published in: Tumor Biology | Issue 7/2014

Login to get access

Abstract

Emerging evidences show that interleukin-8 (IL-8) has important regulatory functions in tumorigenesis. IL-8 -251A/T is a single nucleotide polymorphism in the promoter region of the IL-8 gene and affects IL-8 production. Analysis of previous studies on the association of -251A/T polymorphism with different cancer types remained to be illustrated. To further assess the effect of -251A/T polymorphism on cancer risks, we performed this meta-analysis, up to November 2013, of 12,917 cases with different cancer types and 17,689 controls from 47 published case-control designed studies. Statistical analyses were performed using STATA 11.0 software. Crude odds ratios (ORs) with 95 % confidence intervals (CIs) were used to assess the strength of associations. ORs with 95 % CIs for IL-8 -251A/T polymorphism and cancer were estimated using fixed- and random-effects models when appropriate. Significantly increased risks were found in overall under the models of A allele vs. T allele, AA vs. TT, and AA vs. AT/TT. Significantly elevated risks were observed in breast cancer under the models of A allele vs. T allele, AT vs. TT, AA/AT vs. TT, and AA vs. AT/TT, and in nasopharyngeal carcinoma under the models of AT vs. TT, AA/AT vs. TT, and AA vs. AT/TT. We found that significantly elevated risks were observed in the Asian population and hospital-based studies in all comparison models. Thus, this meta-analysis indicates that IL-8 -251A/T polymorphism is associated with a significantly increased risk of cancers and may provide evidence-based medical certificate to study the cancer susceptibility.
Literature
1.
Shimizu Y, Kondo S, Shirai A, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 and interleukin-8 gene promoter predicts poor prognosis in tongue cancer. Auris Nasus Larynx. 2008;35:381–9.CrossRefPubMed
2.
3.
Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev. 2005;14:2487–93.CrossRefPubMed
4.
Ye BD, Kim SG, Park JH, et al. The interleukin-8–251 A allele is associated with increased risk of noncardia gastric adenocarcinoma in Helicobacter pylori-infected Koreans. J Clin Gastroenterol. 2009;43:233–9.CrossRefPubMed
5.
Liu CM, Yeh CJ, Yu CC, et al. Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. Oral Dis. 2012;18:307–14.CrossRefPubMed
6.
Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117–25.CrossRefPubMed
7.
Shirai K, Ohmiya N, Taguchi A, et al. Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability. J Gastroenterol Hepatol. 2006;21:1129–35.CrossRefPubMed
8.
Lu W, Pan K, Zhang L, et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631–6.CrossRefPubMed
9.
Lee WP, Tai DI, Lan KH, et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res. 2005;11:6431–41.CrossRefPubMed
10.
Savage SA, Hou L, Lissowska J, et al. Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev. 2006;15:589–91.CrossRefPubMed
11.
Felipe AV, Silva TD, Pimenta CA, et al. Interleukin-8 gene polymorphism and susceptibility to gastric cancer in a Brazilian population. Biol Res. 2012;45:369–74.CrossRefPubMed
12.
Vinagre RM, Corvelo TC, Arnaud VC, et al. Determination of strains of Helicobacter pylori and of polymorphism in the interleukin-8 gene in patients with stomach cancer. Arq Gastroenterol. 2011;48:46–51.CrossRefPubMed
13.
Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, et al. Assessment of the toll-like receptor 4 Asp299Gly, Thr399Ile and interleukin-8–251 polymorphisms in the risk for the development of distal gastric cancer. BMC Cancer. 2007;7:70.PubMedCentralCrossRefPubMed
14.
Canedo P, Castanheira-Vale AJ, Lunet N, et al. The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev. 2008;17:28–32.CrossRefPubMed
15.
Ohyauchi M, Imatani A, Yonechi M, et al. The polymorphism interleukin 8–251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut. 2005;54:330–5.PubMedCentralCrossRefPubMed
16.
Kang JM, Kim N, Lee DH, et al. The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol. 2009;43:420–8.CrossRefPubMed
17.
Kamali-Sarvestani E, Bazargani A, Masoudian M, et al. Association of H. pylori cagA and vacA genotypes and IL-8 gene polymorphisms with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol. 2006;12:5205–10.PubMedCentralPubMed
18.
Crusius JB, Canzian F, Capellá G, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol. 2008;19:1894–902.CrossRefPubMed
19.
Ko KP, Park SK, Cho LY, et al. Soybean product intake modifies the association between interleukin-10 genetic polymorphisms and gastric cancer risk. J Nutr. 2009;139:1008–12.CrossRefPubMed
20.
Zhang L, Du C, Guo X, et al. Interleukin-8-251A/T polymorphism and Helicobacter pylori infection risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China. Mol Biol Rep. 2010;37:3983–9.CrossRefPubMed
21.
Bo S, Dianliang Z, Hongmei Z, et al. Association of interleukin-8 gene polymorphism with cachexia from patients with gastric cancer. J Interferon Cytokine Res. 2010;30:9–14.CrossRefPubMed
22.
Savage SA, Abnet CC, Mark SD, et al. Variants of the IL8 and IL8RB genes and risk for gastric for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13:2251–7.PubMed
23.
Rafrafi A, Chahed B, Kaabachi S, et al. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: a case control study. Hum Immunol. 2013;74:1368–74.CrossRefPubMed
24.
Campa D, Hung RJ, Mates D, et al. Lack of association between -251 T>A polymorphism of IL8 and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14:2457–8.CrossRefPubMed
25.
Campa D, Zienolddiny S, Maggini V, et al. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis. 2004;25:229–35.CrossRefPubMed
26.
Vogel U, Christensen J, Wallin H, et al. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res. 2008;639:89–100.CrossRefPubMed
27.
Theodoropoulos G, Papaconstantinou I, Felekouras E, et al. Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol. 2006;12:5037–43.PubMedCentralPubMed
28.
Cacev T, Radosević S, Krizanac S, et al. Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis. 2008;29:1572–80.CrossRefPubMed
29.
Landi S, Moreno V, Gioia-Patricola L, et al. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res. 2003;63:3560–6.PubMed
30.
Vogel U, Christensen J, Dybdahl M, et al. Prospective study of interaction between alcohol, NSAID use and polymorphisms in genes involved in the inflammatory response in relation to risk of colorectal cancer. Mutat Res. 2007;624:88–100.CrossRefPubMed
31.
Wilkening S, Tavelin B, Canzian F, et al. Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis. 2008;29:1202–6.CrossRefPubMed
32.
Gunter MJ, Canzian F, Landi S, et al. Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2006;15:1126–31.CrossRefPubMed
33.
Smith KC, Bateman AC, Fussell HM, et al. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur J Immunogenet. 2004;31:167–73.CrossRefPubMed
34.
Snoussi K, Mahfoudh W, Bouaouina N, et al. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol. 2006;67:13–21.CrossRefPubMed
35.
Kamali-Sarvestani E, Aliparasti MR, Atefi S. Association of interleukin-8 (IL-8 or CXCL8) -251 T/A and CXCR2 + 1208C/T gene polymorphisms with breast cancer. Neoplasma. 2007;54:484–9.PubMed
36.
Snoussi K, Mahfoudh W, Bouaouina N, et al. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility aggressiveness. BMC Cancer. 2010;10:283.PubMedCentralCrossRefPubMed
37.
Vogel U, Christensen J, Nexø BA, et al. Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. Carcinogenesis. 2007;28:427–34.CrossRefPubMed
38.
McCarron SL, Edwards S, Evans PR, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res. 2002;62:3369–72.PubMed
39.
Yang HP, Woodson K, Taylor PR, et al. Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial. Eur J Cancer Prev. 2006;15:249–53.CrossRefPubMed
40.
Michaud DS, Daugherty SE, Berndt SI, et al. Genetic polymorphisms of interleukin-1B(IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res. 2006;66:4525–30.CrossRefPubMed
41.
Wang MH, Helzlsouer KJ, Smith MW, et al. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate. 2009;69:874–85.PubMedCentralCrossRefPubMed
42.
Ben Nasr H, Chahed K, Mestiri S, et al. Association of IL-8 (-251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma. Hum Immunol. 2007;68:761–9.CrossRefPubMed
43.
Wei YS, Lan Y, Tang RG, et al. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol. 2007;125:309–17.CrossRefPubMed
44.
Tai SH, Wei YS, Wang P, et al. Genetic polymorphisms of interferon-C and interleukin-8 in patients with nasopharyngeal carcinoma. J Sichuan Univ (Med Sci Edi). 2007;38:862–5.
45.
Campa D, Hashibe M, Zaridze D, et al. Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. Cancer Causes Control. 2007;18:449–55.CrossRefPubMed
46.
Kietthubthew S, Wickliffe J, Sriplung H, et al. Association of polymorphisms in proinflammatory cytokine genes with the development of oral cancer in Southern Thailand. Int J Hyg Environ Health. 2010;213:146–52.CrossRefPubMed
47.
Hu YP, Liu B, Su T, et al. IL-8-251single nucleotide polymorphism in the recurrence of squamous cell carcinoma of tongue. J Pract Stomatol. 2012;28:328–32.
48.
Gao LB, Pan XM, Jia J, et al. IL-8–251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. Eur J Cancer. 2010;46(8):1333–43.CrossRefPubMed
49.
Wang N, Zhou R, Wang C, et al. -251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies. Mol Biol Rep. 2012;39(3):2831–41.CrossRefPubMed
50.
Ke J, Zhong R, Zhang T, et al. Replication study in Chinese population and meta-analysis supports association of the 5p15.33 locus with lung cancer. PLoS One. 2013;8:e62485.PubMedCentralCrossRefPubMed
51.
Cheng D, Hao Y, Zhou W, et al. Positive association between Interleukin-8–251A > T polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis. Cancer Cell Int. 2013;13:100.PubMedCentralCrossRefPubMed
52.
Wang Z, Wang C, Zhao Z, et al. Association between -251A > T polymorphism in the interleukin-8 gene and oral cancer risk: a meta-analysis. Gene. 2013;522:168–76.CrossRefPubMed
Metadata
Title
The polymorphism interleukin-8 -251A/T is associated with a significantly increased risk of cancers from a meta-analysis
Authors
Ziliang Wang
Yang Liu
Lina Yang
Sheng Yin
Rongyu Zang
Gong Yang
Publication date
01-07-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 7/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1881-5

Other articles of this Issue 7/2014

Tumor Biology 7/2014 Go to the issue

Review

Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor

Research Article

Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity

Research Article

DNA damage-inducible gene, UNC5A, functions as a tumor-suppressor in bladder cancer

Research Article

Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis

Research Article

Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance

Editorial

Letter regarding “Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis” by Guo et al.
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits